Covid-19 roundup: $71M from DoD to Inovio; Pigs provide clues on Oxford vaccine; Google lends supercomputing to antiviral hunt
Inovio is locked in a legal standoff with its contract manufacturer preventing it from scaling up their vaccine, but that hasn’t stopped the Department of Defense from backing their technology.
On Tuesday, the DoD gave Inovio a $71 million contract to scale up manufacturing of the Cellectra devices that accompany their vaccines. It’s the second contract for a Covid-19 manufacturer DoD has signed this month, after a $60 million deal with Novavax on June 4. Both tranches came after the biotechs were left off the reported list of finalists for Trump’s Operation Warp Speed, although not every name on that list is known.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.